Schulich school of Medicine and Dentistry logo Urology Schulich School of Medicine & Dentistry

UroOncology Fall Retreat

23rd Annual Uro-Oncology Fall Review

September 20-22, 2019
Kingbridge Centre
12750 Jane Street, King City, Ontario
http://kingbridgecentre.com

This year's Special Guests are:
Dr. Badrinath Konety, University of Minnesota
Dr. Fadi Brimo, McGill University
Jeffrey Karnes of the Mayo Clinic

Please save the date and join us!    For more information please call Carol at 519-685-8451

Guest speakers and local faculty will provide interactive learning sessions.  The entire program is informal, encouraging discussion and exchange of ideas. The program starts Friday evening with a welcome buffet dinner, followed by a half-day scientific program Saturday morning with the afternoon being free. There will be a group dinner Saturday evening.  The Scientific Program resumes Sunday morning with adjournment at lunch.

With generous unrestricted educational grants from several industry partners, we have been able to keep the registration costs down at a very low rate of $325 for the entire weekend, which includes accommodation and all meals for registrants.    This is designed as a family-friendly event and we have a spousal registration rate of $200 and children under 16 years of age at $75 each. There will be a supervised children program for Saturday evening. 

If you have never attended the Uro-Oncology Fall Review, you will find this combined program very informative, enjoyable and definitely worthwhile. For those who have attended previous meetings, we don’t need to tell you the scientific quality and the atmosphere will be excellent as always!

Learning Objectives:

*Note:     25% of this program is dedicated to participant interaction

By the end of this year’s program, participants will:

  1. Have received an update on the most recent developments and state of the art management concepts in prostate cancer, bladder and renal cancer.
  2. Received information on new concepts in genitourinary pathology.
  3. Have heard details of complex uro-oncologic cases and interactive review of rationale and relevant latest clinical evidence.
  4. Obtained news of clinical trials available for the difficult/challenging cases.